Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Patient Educ Couns. 2017 Sep 6;101(3):490–496. doi: 10.1016/j.pec.2017.09.003

Table 5.

Agreement on A/V materials the PEMAT (n = 30 materials)

PEMAT Item number Percent Raw Agreement Fleiss Kappa (95% CI) Gwet’s AC1 (95% CI)
1 1 1 (1, 1) 1 (1, 1)
3 0.87 0.26 (−0.29, 0.81) 0.84 (0.66, 1)
4 0.87 −0.07 (−0.15, 0) 0.85 (0.68, 1)
5 1 1 (1, 1) 1 (1, 1)
8 0.77 0.41 (0.02, 0.80) 0.71 (0.50, 0.92)
9 0.70 0.44 (0.11, 0.77) 0.59 (0.35, 0.83)
10 1 1 (1, 1) 1 (1, 1)
11 0.73 0.08 (−0.33, 0.49) 0.69 (0.47, 0.91)
12 0.60 −0.12 (−0.45, 0.21) 0.38 (0, 0.76)
13 0.67 0.24 (−0.13, 0.61) 0.57 (0.33, 0.82)
14 1 1 (1, 1) 1 (1, 1)
18 0.63 0.13 (−0.23, 0.5) 0.54 (0.28, 0.79)
19 0.90 0.52 (0.03, 1) 0.89 (0.76, 1)
20 0.97 −0.02 (−0.05, 0.02) 0.97 (0.89, 1)
21 1 1 (1, 1) 1 (1, 1)
22 0.97 −0.02 (−0.05, 0.02) 0.97 (0.89, 1)
25 0.73 0.06 (−0.33, 0.45) 0.69 (0.47, 0.91)